Phathom Pharmaceuticals Inc

-0.07 (-0.98%)
7:56:08 PM EDT: $7.10 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)406.48M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.71 Million
Adjusted EPS-$1.07
See more estimates
10-Day MA$7.31
50-Day MA$8.96
200-Day MA$11.02
See more pivots

Phathom Pharmaceuticals Inc Stock, NASDAQ:PHAT

100 Campus Drive, Suite 102, Florham Park, New Jersey 07932
United States of America
Phone: +1.877.742.8466
Number of Employees: 112


Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.